Your Diet and Cancer
diet

Did you know that 60-70% of cancers are due to dietary factors? And, that many of these may be prevented by changes in dietary habits?

diet maybe cancer because cancer diet

 Your Diet and Cancer

Do Yourself A Favor - Eat Right And Stay Healthy!

Your Diet and Cancer
by Dr. Radhika Venkata

From: Dean Brenner
Date: Tuesday, December 2, 2008
 

That's right, and now there is an "answer book" for those who want to learn more about taking control of their health.

Your Diet and Cancer is a practical tutorial designed to give the reader valuable information about how cancers develop and how simple changes in diet may prevent serious illness.

Written in plain English, Your Diet and Cancer explores pertinent questions like:

  • Exactly what is cancer?
  • What are risk factors for getting cancer?
  • How diet influences cancer risk
  • The role of diet in actually causing cancer
  • Dietary carcinogens
  • How certain foods may reduce cancer risk
  • How some foods help fight against cancer
  • Common questions about diet and cancer
  • Great tips to use in your daily life

Not to be confused with a medical journal full of technical jargon, this book is jam-packed with over 60 pages of down to earth information and beautiful illustrations of the salient points.

This book is not a replacement for medical treatment or proper diagnosis. It is a reference volume. The ideas and suggestions contained in Your Diet and Cancer are designed to help you make informed decisions about your health.

You have very little to lose and much to gain. Cancer is one of the main causes of death among humans and your way of consuming food affects the risk. Do yourself a favor and take control today!

Dr. Radhika Venkata (Author)

diet or cancer when cancer diet

 
cancer
 

This product earns 1700  Krazy Kash bonus points

 
cancer diet
 
 
 Your Diet and Cancer ORDER NOW!
Only $17
 Accepted Payments
IMMEDIATE DOWNLOAD!

 Place Your Secure Order Now!

 
 
diet
 
 

Our 365-day Guarantee! If you're not 100% completely satisfied, we'll return 100% of everything you paid.
It's the best guarantee in the business!

 100% Satisfaction Guaranteed

We want you to be a happy customer ... If for any reason you are not completely satisfied with the Your Diet and Cancer, just drop us a line (our full details are at the bottom of this page) with a copy of your sales receipt and we'll gladly refund your full purchase amount. No questions asked ... No hassles ... And we can still be friends...

Now that's more than a guarantee ... It's our personal promise to you.

 
 
cancer
 
 
Here are two easy ways to order:
  1. Order Your Diet and Cancer online ... immediate download

  2. Order Your Diet and Cancer by mail

 
cancer diet
 
 
 

To your success!
 Dean Brenner, Webmaster
Dean Brenner
Webmaster
BWS Group

 
 
P.S. You owe it to yourself and your loved ones. Reduce the risk. Order this valuable information and take back control today!
 
 
diet
 

This product earns 1700  Krazy Kash bonus points

 
cancer
 
 
 Your Diet and Cancer ORDER NOW!
Only $17
 Accepted Payments
IMMEDIATE DOWNLOAD!

 Place Your Secure Order Now!

 
 
 
Check Out These Other Great Health Related Titles
Click a title to visit the product website*
 

* Note: A new browser window will open.  When finished viewing,    close the new browser window and you will be returned here.

 

Click a title to visit the product website*

 
cancer diet
 

Do you need more Health-Related information?

Take a look at Improve Your Life. You will be sure to find it there ... and at a nice bargain-basement price as well.

 

* Note: A new browser window will open.  When finished viewing,    close the new browser window and you will be returned here.

 
 
 
 
HostGator: Host Unlimited Web Sites!
 
 
 
 
 
Cancer / Oncology News Informational Articles
 
Tue, 02 Dec 2008 04:00:00 PST
Five Steps To Saving Lives And Improving Men's Experience Of Prostate Cancer By 2020
The Prostate Cancer Charity is launching a new strategy 'Transforming The Future For Prostate Cancer' - which it believes could reduce mortality rates by 30 per cent. The strategy, which will be unveiled at a special event next Monday (1 December), outlines ambitious goals and targets for vital changes the Charity believes are necessary to improve men's experience of prostate cancer by 2020.
 
Tue, 02 Dec 2008 04:00:00 PST
Breakthrough Breast Cancer In Response To The Publication Of The Cancer Reform Strategy 1 Year On Report Published By The Department Of Health Today
Jeremy Hughes, Chief Executive of Breakthrough Breast Cancer says: "The Cancer Reform Strategy (CRS) has made steady progress since its publication last year. Breakthrough is particularly delighted to see our Service Pledge for Breast Cancer - a tool developed to enable health professionals and patients work together towards improved breast cancer services - is highlighted in today's report.
 
Tue, 02 Dec 2008 03:00:00 PST
Nationwide Study Confirms PET As The Most Powerful Imaging Tool In Cancer Management
With the most recent release of data from the National Oncologic PET Registry (NOPR), researchers may have reached the moment of critical mass by confirming the effectiveness of positron emission tomography (PET) in the monitoring of tumor activity across a wide range of cancers.
 
Tue, 02 Dec 2008 03:00:00 PST
Ark Files Cerepro(R) Application For Marketing Authorisation With EMEA
Ark Therapeutics Group plc (AKT: LSE) ("Ark" or "the Company") today announces that the Marketing Authorisation Application (MAA) for Cerepro®, Ark's novel gene-based therapy for operable malignant glioma (brain cancer), has been filed with the European medicines regulatory agency (EMEA). The MAA application for Cerepro®, filed following a pre-submission meeting with the EMEA, will now enter the validation stage, prior to commencing formal review.
 
Tue, 02 Dec 2008 01:00:00 PST
Study Demonstrates The Benefit Of Using Chemoradiotherapy In Elderly Patients With Locally Advanced Oesophageal Cancer
Chemoradiotherapy (CRT) can be considered an "effective" treatment for elderly patients with locally advanced oesophageal cancer, reports the British Journal of Cancer. The French study, involving 109 consecutive patients with oesophageal cancer, suggests that characterising patients first with the "Charlson" score may provide useful criteria for deciding which subjects are suitable for treatment.
 
Tue, 02 Dec 2008 01:00:00 PST
Wistar Scientists Find Key To Keeping Killer T Cells In Prime Shape For Fighting Infection, Cancer
Like tuning a violin to produce strong, elegant notes, researchers at The Wistar Institute have found multiple receptors on the outside of the body's killer immune system cells which they believe can be selectively targeted to keep the cells in superb infection- and disease-fighting condition.
 
Tue, 02 Dec 2008 01:00:00 PST
IDO2 An Active Enzyme To Target In Pancreatic Cancer
An enzyme that is overexpressed in pancreatic cancer cells may hold the key to successfully treating the disease with targeted immunotherapy, researchers from Thomas Jefferson University reported at the 2008 Annual Meeting of the Southern Surgical Association. Previous data show that a protein, indoleamine 2,3-dioxygenase (IDO), is overexpressed in pancreatic ductal adenocarcinomas, according to Jonathan R. Brody, Ph.D.
 
Tue, 02 Dec 2008 00:00:00 PST
Vical Receives Milestone Payment From Merck & Co., Inc. Triggered By Planned Initiation Of Investigational Cancer DNA Vaccine Trial
Vical Incorporated (Nasdaq: VICL) announced the receipt of a $1.0 million milestone payment from Merck & Co., Inc. based on Merck's planned initiation of a Phase I clinical trial of an investigational plasmid DNA (pDNA) cancer vaccine. The candidate vaccine is based on Vical's DNA gene delivery technology and encodes human telomerase reverse transcriptase (hTERT). hTERT is the subject of separate license agreement.
 
Mon, 01 Dec 2008 09:00:00 PST
Marshall Edwards, Inc. Files IND Application For Triphendiol - Locally Advanced Or Metastatic Pancreatic And Bile Duct Cancers
Marshall Edwards, Inc. (NASDAQ: MSHL) today announced that it has filed an application with the United States Food and Drug Administration for an Investigative New Drug (IND) approval to undertake clinical studies with triphendiol as a chemosensitizing agent in combination with gemcitabine.
 
Mon, 01 Dec 2008 08:00:00 PST
Earlier Detection Of Cancer And Better Treatment For Survivors, UK
Work is well underway to catch more cancer cases earlier and improve the longer term treatment for cancer survivors, National Cancer Director Professor Mike Richards said today. The first annual report setting out the Government's progress against the Cancer Reform Strategy, "Maintaining Momentum, Building for the Future", highlights the achievements made in the first year and identifies priorities for the year ahead.
 
 
The Millionaire League: Be The Next Internet Millionaire!
 
 
* Any testimonials and/or examples used may be exceptional results which may not apply to the average person. They are not intended to represent or guarantee that anyone who purchases and/or uses this product will acheive the same or similar results. Each individual's success depends on their background, dedication, desire and motivation.

BWS Group - The Home Of Over 415+ Products and Services

BWS Group
7 West Center Street    Suite 4
Mount Morris, IL 61054

eMail: support@bwsgroup.net

 
Copyright 2003, 2008    BWS Group    All rights reserved worldwide
Information in this document is subject to change without notice.
Web site by BWS Group